Hepatitis a adult vaccine/hepatitis b adult vaccine Disease Interactions
There are 4 disease interactions with hepatitis a adult vaccine / hepatitis b adult vaccine.
Hepatitis A adult vaccine (applies to hepatitis a adult vaccine/hepatitis b adult vaccine) liver disease
Moderate Potential Hazard, Moderate plausibility.
The use of hepatitis A adult vaccine in patients with chronic liver disease may have lower antibody response to the vaccine. Monitoring is recommended when vaccinating these patients.
References
- "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
Hepatitis A vaccine (applies to hepatitis a adult vaccine/hepatitis b adult vaccine) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The use of hepatitis A vaccine in immunocompromised persons, including individuals receiving immunosuppressive therapy, may result in diminished immune response to the vaccine and these patients may not be protected against hepatitis A virus. Monitoring is recommended when vaccinating these patients.
References
- "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
- (2022) "Product Information. Vaqta (hepatitis A adult vaccine)." Merck & Co., Inc
Hepatitis A vaccine (applies to hepatitis a adult vaccine/hepatitis b adult vaccine) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
The use of hepatitis A vaccine in patients with chronic liver disease may result in lower antibody response. Care should be exercised when using this agent in patients with liver disease.
References
- "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
Hepatitis B vaccine (applies to hepatitis a adult vaccine/hepatitis b adult vaccine) hemophilia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Bleeding Associated with Coagulation Defect
Hepatitis B vaccine (adult and pediatric) is usually for intramuscular administration. However, it may be administered subcutaneously to persons at risk for hemorrhage following intramuscular injections (e.g., hemophiliacs), although it may result in lower antibody response. Additionally, when other aluminum- absorbed vaccines have been administered subcutaneously, an increased incidence of local reactions including subcutaneous nodules has been observed. Therefore, consider subcutaneous administration only in persons who are at risk of hemorrhage following intramuscular injections.
References
- (2022) "Product Information. Engerix-B Pediatric (HepB) (hepatitis B pediatric vaccine)." GlaxoSmithKline
- (2022) "Product Information. Recombivax HB Pediatric/Adolescent (hepatitis B pediatric vaccine)." Merck & Co., Inc
Hepatitis a adult vaccine/hepatitis b adult vaccine drug interactions
There are 288 drug interactions with hepatitis a adult vaccine / hepatitis b adult vaccine.
More about hepatitis a adult vaccine / hepatitis b adult vaccine
- hepatitis a adult vaccine/hepatitis b adult vaccine consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vaccine combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.